1
|
Serrano-Alonso M, Guillen-Grima F, Martin-Moreno P, Rabago G, Manrique J, Garcia-del-Barrio M, Reina G, Torre-Cisneros J, Fernandez-Alonso M, Herrero J. Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation. Transpl Infect Dis 2018; 20:e12873. [DOI: 10.1111/tid.12873] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Revised: 01/02/2018] [Accepted: 01/14/2018] [Indexed: 01/06/2023]
Affiliation(s)
| | - F. Guillen-Grima
- Preventive Medicine Department; Clínica Universidad de Navarra; Pamplona Spain
- Department of Health Sciences; Public University of Navarra; Pamplona Spain
- Navarra's Health Research Institute (IdiSNA); Pamplona Spain
| | - P. Martin-Moreno
- Navarra's Health Research Institute (IdiSNA); Pamplona Spain
- Nephrology Department; Clínica Universidad de Navarra; Pamplona Spain
| | - G. Rabago
- Cardiac Surgery Department; Clínica Universidad de Navarra; Pamplona Spain
| | - J. Manrique
- Navarra's Health Research Institute (IdiSNA); Pamplona Spain
- Nephrology Department; Complejo Hospitalario de Navarra; Pamplona Spain
| | | | - G. Reina
- Navarra's Health Research Institute (IdiSNA); Pamplona Spain
- Microbiology Department; Clínica Universidad de Navarra; Pamplona Spain
| | - J. Torre-Cisneros
- Maimonides Biomedical Research Institute of Cordoba (IMIBIC); Reina Sofía University Hospital; University of Cordoba; Cordoba Spain
| | - M. Fernandez-Alonso
- Navarra's Health Research Institute (IdiSNA); Pamplona Spain
- Microbiology Department; Clínica Universidad de Navarra; Pamplona Spain
| | - J.I. Herrero
- Navarra's Health Research Institute (IdiSNA); Pamplona Spain
- Liver Unit; Clínica Universidad de Navarra; Pamplona Spain
- Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd); Madrid Spain
| |
Collapse
|
2
|
Aguilera A, Navarro D, Rodríguez-Frias F, Viciana I, Martínez-Sapiña AM, Rodríguez MJ, Martró E, Lozano MC, Coletta E, Cardeñoso L, Suárez A, Trigo M, Rodríguez-Granjer J, Montiel N, de la Iglesia A, Alados JC, Vegas C, Bernal S, Fernández-Cuenca F, Pena MJ, Reina G, García-Bujalance S, Echevarria MJ, Benítez L, Pérez-Castro S, Ocete D, García-Arata I, Guerrero C, Rodríguez-Iglesias M, Casas P, García F. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study). J Viral Hepat 2017; 24:725-732. [PMID: 28248445 DOI: 10.1111/jvh.12700] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Accepted: 02/09/2017] [Indexed: 12/11/2022]
Abstract
We report the largest study on the prevalence and distribution of HCV genotypes in Spain (2000-2015), and we relate them with clinical, epidemiological and virological factors. Patients from 29 hospitals in 10 autonomous communities (Andalusia, Aragon, Castilla-Leon, Catalonia, Galicia, Canary Islands, Madrid Community, Valencian Community, Murcia Region and Basque Country) have been studied. Annual distribution of HCV genotypes and subtypes, as well as gender, age, transmission route, HIV and/or HBV coinfection, and treatment details were recorded. We included 48595 chronically HCV-infected patients with the following characteristics: median age 51 years (IQR, 44-58), 67.9% male, 19.1% HIV-coinfected, 23.5% HBV-coinfected. Parenteral transmission route was the most frequent (58.7%). Genotype distribution was 66.9% GT1 (24.9% subtype 1a and 37.9% subtype 1b), 2.8% GT2, 17.3% GT3, 11.4% GT4 and 0.1% GT5 and 0.02% GT6. LiPA was the most widely HCV genotyping test used (52.4%). HCV subtype 1a and genotypes 3 and 4 were closely associated with male gender, parenteral route of infection and HIV and HBV coinfection; in contrast, subtype 1b and genotype 2 were associated with female gender, nonparenteral route and mono-infection. Age was related to genotype distribution, and different patterns of distribution and biodiversity index were observed between different geographical areas. Finally, we describe how treatment and changes in transmission routes may have affected HCV genotype prevalence and distribution patterns. We present the most recent data on molecular epidemiology of hepatitis C virus in Spain. This study confirms that genotype distributions vary with age, sex, HIV and HBV coinfection and within geographical areas and epidemiological groups.
Collapse
Affiliation(s)
- A Aguilera
- Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain
| | - D Navarro
- Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain
| | | | - I Viciana
- Hospital Clínico Universitario Virgen de la Victoria, Malaga, Spain
| | | | | | - E Martró
- Hospital Universitari Germans Trías i Pujol, Badalona, CIBER en Epidemiología y Salud Pública, Barcelona, Spain
| | - M C Lozano
- Hospital Universitario Virgen del Rocio, Sevilla, Spain
| | - E Coletta
- Hospital Clínico Universitario Valladolid, Valladolid, Spain
| | - L Cardeñoso
- Hospital Universitario de la Princesa, Madrid, Spain
| | - A Suárez
- Hospital Clínico San Carlos, Madrid, Spain
| | - M Trigo
- Complexo Hospitalario de Pontevedra, Pontevedra, Spain
| | | | - N Montiel
- Hospital Costa del Sol, Marbella, Spain
| | - A de la Iglesia
- Complejo Hospitalario Universitario de Huelva, Huelva, Spain
| | - J C Alados
- Hospital del SAS de Jerez de la Frontera, Sevilla, Spain
| | - C Vegas
- Fundación Jiménez Díaz, Madrid, Spain
| | - S Bernal
- Hospital Universitario Virgen de Valme, Sevilla, Spain
| | | | - M J Pena
- Hospital Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain
| | - G Reina
- Clínica Universitaria de Navarra, Pamplona, Spain
| | | | | | - L Benítez
- Hospital Universitario Puerta de Hierro, Majadahonda, Spain
| | | | - D Ocete
- Consorcio Hospital General Universitario de Valencia, Valencia, Spain
| | - I García-Arata
- Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain
| | - C Guerrero
- Hospital General Universitario Morales Meseguer, Murcia, Spain
| | | | - P Casas
- Hospital Universitario San Cecilio, Instituto de Investigación Ibs-Granada, Granada, Spain
| | - F García
- Hospital Universitario San Cecilio, Instituto de Investigación Ibs-Granada, Granada, Spain
| |
Collapse
|
3
|
Affiliation(s)
- A. Amendola
- Commission of the European Communities, Joint Research Centre, Ispra Establishment, 1-21020 Ispra, Italy
| | - G. Reina
- University of Milano and Studio MESA, Via Carnaghi, 15, Milano, Italy
| |
Collapse
|
4
|
Kartashev V, Döring M, Nieto L, Coletta E, Kaiser R, Sierra S, Guerrero A, Stoiber H, Paar C, Vandamme A, Nevens F, Ranst MV, Cuypers L, Braun P, Ehret R, Obermeier M, Schneeweiss S, Scholten S, Römer K, Isernhagen K, Qurashi N, Heger E, Knops E, Neumann-Fraune M, Timm J, Walker A, Lübke N, Wedemeyer H, Wiesch JSZ, Lütgehetmann M, Polywka S, Däumer M, Hoffmann D, Protzer U, Marascio N, Foca A, Liberto M, Barreca G, Galati L, Torti C, Pisani V, Perno C, Ceccherini-Silberstein F, Cento V, Ciotti M, Zazzi M, Rossetti B, Luca A, Caudai C, Mor O, Devaux C, Staub T, Araujo F, Gomes P, Cabanas J, Markin N, Khomenko I, Govorukhina M, Lugovskaya G, Dontsov D, Mas A, Martró E, Saludes V, Rodríguez-Frías F, García F, Casas P, Iglesia ADL, Alados J, Pena-López M, Rodríguez M, Galán J, Suárez A, Cardeñoso L, Guerrero M, Vegas-Dominguez C, Blas-Espada J, García R, García-Bujalance S, Benítez-Gutiérrez L, Mendoza CD, Montiel N, Santos J, Viciana I, Delgado A, Martínez-Sanchez P, Fernández-Alonso M, Reina G, Trigo M, Echeverría M, Aguilera A, Navarro D, Bernal S, Lozano M, Fernández-Cuenca F, Orduña A, Eiros J, Lejarazu ROD, Martínez-Sapiña A, García-Díaz A, Haque T. New findings in HCV genotype distribution in selected West European, Russian and Israeli regions. J Clin Virol 2016; 81:82-9. [DOI: 10.1016/j.jcv.2016.05.010] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2016] [Revised: 05/17/2016] [Accepted: 05/19/2016] [Indexed: 02/06/2023]
|
5
|
Reina G, Orlanducci S, Cairone C, Tamburri E, Lenti S, Cianchetta I, Rossi M, Terranova ML. Rhodamine/Nanodiamond as a System Model for Drug Carrier. J Nanosci Nanotechnol 2015; 15:1022-1029. [PMID: 26353608 DOI: 10.1166/jnn.2015.9736] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
In this paper we present some strategies that are being developed in our labs towards enabling nanodiamond-based applications for drug delivery. Rhodamine B (RhB) has been choosen as model molecule to study the loading of nanodiamonds with active moieties and the conditions for their controlled release. In order to test the chemical/physical interactions between functionalized detonation nanodiamond (DND) and complex molecules, we prepared and tested different RhB@DND systems, with RhB adsorbed or linked by ionic bonding to the DND surface. The chemical state of the DND surfaces before conjugation with the RhB molecules, and the chemical features of the DND-RhB interactions have been deeply analysed by coupling DND with Au nanoparticles and taking advantage of surface enhanced Raman spectroscopy SERS. The effects due to temperature and pH variations on the process of RhB release from the DND carrier have been also investigated. The amounts of released molecules are consistent with those required for effective drug action in conventional therapeutic applications, and this makes the DND promising nanostructured cargos for drug delivery applications.
Collapse
|
6
|
Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, Chamorro J, Ortega MT, Albéniz E, Pozo F, Ezpeleta C. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. ACTA ACUST UNITED AC 2014; 19. [PMID: 24556347 DOI: 10.2807/1560-7917.es2014.19.6.20700] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).
Collapse
Affiliation(s)
- J Castilla
- Instituto de Salud Publica de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Flanagan NS, Mosquera Espinosa AT, González RT, Molineros Hurtado FH, Ospina Calderón NH, Cuartas Domínguez M, Silverstone Sopkin PA, Reina G, Diez MC, Ospina Torres R, Ackerman JD, Bayman P, Otero JT. Research Group in Orchids, Ecology and Plant Systematics: an inter-institutional initiative for plant conservation and sustainable use in south-west Colombia. Lankesteriana 2013. [DOI: 10.15517/lank.v0i0.11624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
8
|
Castilla J, Martinez-Baz I, Martinez-Artola V, Fernandez-Alonso M, Reina G, Guevara M, Garcia Cenoz M, Elia F, Alvarez N, Barricarte A, Ezpeleta C. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill 2013; 18:2. [PMID: 23449182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenzalike illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Case-Control Studies
- Child
- Child, Preschool
- Female
- Hospitalization
- Humans
- Incidence
- Influenza A Virus, H1N1 Subtype/immunology
- Influenza A Virus, H1N1 Subtype/isolation & purification
- Influenza A Virus, H3N2 Subtype/immunology
- Influenza A Virus, H3N2 Subtype/isolation & purification
- Influenza A Virus, H3N8 Subtype/immunology
- Influenza A Virus, H3N8 Subtype/isolation & purification
- Influenza B virus/immunology
- Influenza B virus/isolation & purification
- Influenza Vaccines/administration & dosage
- Influenza Vaccines/immunology
- Influenza, Human/epidemiology
- Influenza, Human/prevention & control
- Influenza, Human/virology
- Logistic Models
- Male
- Middle Aged
- Population Surveillance
- Prospective Studies
- Seasons
- Spain/epidemiology
- Treatment Outcome
- Vaccination/statistics & numerical data
- Young Adult
Collapse
Affiliation(s)
- J Castilla
- Instituto de Salud Publica de Navarra-Public Health Institute of Navarre, Pamplona, Spain.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Castilla J, Martínez-Baz I, Martínez-Artola V, Fernandez-Alonso M, Reina G, Guevara M, García Cenoz M, Elía F, Alvarez N, Barricarte A, Ezpeleta C. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill 2013. [DOI: 10.2807/ese.18.07.20404-en] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- J Castilla
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - I Martínez-Baz
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
| | - V Martínez-Artola
- Complejo Hospitalario de Navarra (Hospital Complex of Navarre), Pamplona, Spain
| | - M Fernandez-Alonso
- Clínica Universidad de Navarra (University Clinic of Navarre), Pamplona, Spain
| | - G Reina
- Clínica Universidad de Navarra (University Clinic of Navarre), Pamplona, Spain
| | - M Guevara
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - M García Cenoz
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - F Elía
- Primary Healthcare Directorate, Navarre Health Service, Pamplona, Spain
| | - N Alvarez
- Servicio Navarro de Salud (Navarre Health Service), Pamplona, Spain
| | - A Barricarte
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - C Ezpeleta
- Complejo Hospitalario de Navarra (Hospital Complex of Navarre), Pamplona, Spain
| |
Collapse
|
10
|
Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Moran J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A, Primary Health Care Sentinel Network C, Network for Influenza Surveillance in Hospitals of Navarre C. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013; 18. [DOI: 10.2807/ese.18.05.20388-en] [Citation(s) in RCA: 104] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- J Castilla
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - I Martínez-Baz
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
| | - V Martínez-Artola
- Complejo Hospitalario de Navarra (Hospital complex of Navarre), Pamplona, Spain
| | - G Reina
- Clínica Universidad de Navarra (University Clinic of Navarre), Pamplona, Spain
| | - F Pozo
- National Centre of Microbiology (World Health Organization National Influenza Centre - Madrid), Instituto de Salud Carlos III, Majadahonda, Spain
| | - M García Cenoz
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - M Guevara
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - J Moran
- Primary Healthcare Directorate, Navarre Health Service, Pamplona, Spain
| | - F Irisarri
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
| | - M Arriazu
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - E Albéniz
- Primary Healthcare Directorate, Navarre Health Service, Pamplona, Spain
| | - C Ezpeleta
- Complejo Hospitalario de Navarra (Hospital complex of Navarre), Pamplona, Spain
| | - A Barricarte
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP; Network of Biomedical Research Centers Epidemiology and Public Health), Spain
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | | | | |
Collapse
|
11
|
Grottel S, Beck P, Muller C, Reina G, Roth J, Trebin HR, Ertl T. Visualization of Electrostatic Dipoles in Molecular Dynamics of Metal Oxides. IEEE Trans Vis Comput Graph 2012; 18:2061-2068. [PMID: 26357112 DOI: 10.1109/tvcg.2012.282] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Metal oxides are important for many technical applications. For example alumina (aluminum oxide) is the most commonly-used ceramic in microelectronic devices thanks to its excellent properties. Experimental studies of these materials are increasingly supplemented with computer simulations. Molecular dynamics (MD) simulations can reproduce the material behavior very well and are now reaching time scales relevant for interesting processes like crack propagation. In this work we focus on the visualization of induced electric dipole moments on oxygen atoms in crack propagation simulations. The straightforward visualization using glyphs for the individual atoms, simple shapes like spheres or arrows, is insufficient for providing information about the data set as a whole. As our contribution we show for the first time that fractional anisotropy values computed from the local neighborhood of individual atoms of MD simulation data depict important information about relevant properties of the field of induced electric dipole moments. Iso surfaces in the field of fractional anisotropy as well as adjustments of the glyph representation allow the user to identify regions of correlated orientation. We present novel and relevant findings for the application domain resulting from these visualizations, like the influence of mechanical forces on the electrostatic properties.
Collapse
Affiliation(s)
- S Grottel
- Computer Graphics and Visualization Lab of the TU Dresden (CGV, Dresden University of Technology).
| | | | | | | | | | | | | |
Collapse
|
12
|
Castilla J, Cía F, Zubicoa J, Reina G, Martínez-Artola V, Ezpeleta C. Influenza outbreaks in nursing homes with high vaccination coverage in Navarre, Spain, 2011/12. Euro Surveill 2012. [DOI: 10.2807/ese.17.14.20141-en] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In the 2011/12 season, three influenza outbreaks were studied in nursing homes with high vaccination coverage in Navarre, Spain. Attack rates ranged from 2.9% to 67%. Influenza A/Stockholm/18/2011(H3N2) virus strain was isolated from the three outbreaks. Vaccination should be complemented with other hygiene measures in nursing homes. Early detection of influenza outbreaks in nursing homes can aid in their control.
Collapse
Affiliation(s)
- J Castilla
- CIBER Epidemiología y Salud Pública, Spain
- Instituto de Salud Pública de Navarra, Pamplona, Spain
| | - F Cía
- Red de Médicos Centinela de Gripe de Navarra, Pamplona, Spain
| | - J Zubicoa
- Red de Médicos Centinela de Gripe de Navarra, Pamplona, Spain
| | - G Reina
- Clínica Universidad de Navarra, Pamplona, Spain
| | | | - C Ezpeleta
- Complejo Hospitalario de Navarra, Pamplona, Spain
| |
Collapse
|
13
|
Castilla J, Cia F, Zubicoa J, Reina G, Martínez-Artola V, Ezpeleta C. Influenza outbreaks in nursing homes with high vaccination coverage in Navarre, Spain, 2011/12. Euro Surveill 2012; 17:20141. [PMID: 22516002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023] Open
Abstract
In the 2011/12 season, three influenza outbreaks were studied in nursing homes with high vaccination coverage in Navarre, Spain. Attack rates ranged from 2.9% to 67%. Influenza A/Stockholm/18/2011(H3N2) virus strain was isolated from the three outbreaks. Vaccination should be complemented with other hygiene measures in nursing homes. Early detection of influenza outbreaks in nursing homes can aid in their control.
Collapse
Affiliation(s)
- J Castilla
- Instituto de Salud Publica de Navarra, Pamplona, Spain.
| | | | | | | | | | | |
Collapse
|
14
|
Castilla J, Moran J, Martinez-Artola V, Reina G, Martinez-Baz I, Garcia Cenoz M, Alvarez N, Irisarri F, Arriazu M, Elia F, Salcedo E. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill 2011; 16:19799. [PMID: 21345321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023] Open
Abstract
We defined a cohort of people with major chronic conditions (152,585 subjects) in Navarre, Spain, using electronic records from physicians, to obtain 2010/11 mid-season estimates of influenza vaccine effectiveness. The adjusted estimates of the effectiveness of the 2010/11 trivalent influenza vaccine were 31% (95% confidence interval (CI): 20–40%) in preventing medically attended influenza-like illness, and 58% (95% CI: 11–80%) in preventing laboratory-confirmed influenza. Having received the monovalent influenza A(H1N1)2009 vaccine in the 2009/10 season had an independent preventive effect against medically attended influenza-like illness (17%, 95% CI: 1–30%), and having received both vaccines had 68% (95% CI: 23–87%) effectiveness in preventing laboratory-confirmed influenza.
Collapse
Affiliation(s)
- J Castilla
- Public Health Institute of Navarre, Pamplona, Spain.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Castilla J, Moran J, Martínez-Artola V, Reina G, Martínez-Baz I, García Cenoz M, Alvarez N, Irisarri F, Arriazu M, Elía F, Salcedo E. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill 2011. [DOI: 10.2807/ese.16.07.19799-en] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- J Castilla
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- CIBER de Epidemiología y Salud Pública (Biomedical Research Network of Epidemiology and Public Health)
| | - J Moran
- Dirección de Atención Primaria, Servicio Navarro de Salud (Primary Health Care Department), Pamplona, Spain
| | - V Martínez-Artola
- Complejo Hospitalario de Navarra (Navarre Hospital Complex), Pamplona, Spain
| | - G Reina
- Clínica Universidad de Navarra (University Clinic of Navarra), Pamplona, Spain
| | - I Martínez-Baz
- CIBER de Epidemiología y Salud Pública (Biomedical Research Network of Epidemiology and Public Health)
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - M García Cenoz
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- CIBER de Epidemiología y Salud Pública (Biomedical Research Network of Epidemiology and Public Health)
| | - N Alvarez
- Servicio Navarro de Salud (Navarre Health Service), Pamplona, Spain
| | - F Irisarri
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
- CIBER de Epidemiología y Salud Pública (Biomedical Research Network of Epidemiology and Public Health)
| | - M Arriazu
- CIBER de Epidemiología y Salud Pública (Biomedical Research Network of Epidemiology and Public Health)
- Instituto de Salud Pública de Navarra (Public Health Institute of Navarre), Pamplona, Spain
| | - F Elía
- Dirección de Atención Primaria, Servicio Navarro de Salud (Primary Health Care Department), Pamplona, Spain
| | - E Salcedo
- Complejo Hospitalario de Navarra (Navarre Hospital Complex), Pamplona, Spain
| |
Collapse
|
16
|
Castilla J, Morán J, Fernández-Alonso M, Martínez Artola V, Zamora MJ, Mazón A, Fernández C, García Cenoz M, Elía F, Reina G, Salcedo E, Irisarri F, Barricarte A. [The 2009 H1N1 flu pandemic in Navarre, Spain]. An Sist Sanit Navar 2011; 33:287-95. [PMID: 21233864 DOI: 10.4321/s1137-66272010000400005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND To describe flu activity during the 2009-2010 pandemic in Navarre and compare it to previous seasons. METHODS An analysis was made of all flu cases reported in primary care and all the virological confirmations made in patients in primary care and in hospitals of Navarre between week 21 of 2009 and week 20 of 2010. RESULTS Influenza A (H1N1) Virus 2009 was detected in Navarre between week 23 of 2009 and week 2 of 2010, a period when 39 medically diagnosed cases of flu syndrome per 1,000 inhabitants were registered. The epidemic threshold was surpassed in two periods, with a peak in July and a greater one in November. The greatest incidence was reached in children aged between 5 and 14 years (121 per thousand), followed by the group of under fives. There were 224 hospitalisations (36 per 100,000 inhabitants) with confirmation of Influenza A (H1N1) Virus 2009, 8% of whom required admission to intensive care units and there were four deaths (0.6 per 100,000 inhabitants). The rate of hospitalisation was greater amongst children under five (163 per 100,000 inhabitants), while the probability of referral to intensive care increased with age. CONCLUSION In spite of not having a specific vaccine available until the season was very well advanced, Influenza A (H1N1)Virus 2009 produced a flu wave with similar levels to those of other seasons and its repercussion in hospitalisations and serious cases was moderate.
Collapse
|
17
|
Abstract
BACKGROUND Statins represent a modern mainstay of the drug treatment of coronary artery disease and acute coronary syndromes. Reduced aerobic work performance and slowed VO(2) kinetics are established features of the clinical picture of post-myocardial infarction (MI) patients. We tested the hypothesis that statin therapy improves VO(2) exercise performance in normocholesterolaemic post-MI patients. MATERIALS AND METHODS According to a double-blinded, randomized, crossover and placebo-controlled study design, in 18 patients with uncomplicated recent (3 days) MI we investigated the effects of atorvastatin (20 mg day(-1)) on gas exchange kinetics by calculating VO(2) effective time constant (tau) during a 50-watt constant workload exercise, brachial artery flow-mediated dilatation (FMD) as an index of endothelial function, left ventricular function (echocardiography) and C-reactive protein (CRP, as an index of inflammation). Atorvastatin or placebo was given for 3 months each. RESULTS Atorvastatin therapy significantly improved exercise VO(2) tau and FMD, and reduced CRP levels. We did not observe changes in cardiac contractile function and relaxation properties during all study periods in either group. CONCLUSIONS In post-MI patients exercise performance is a potential additional target of benefits related to statin therapy. Endothelial function improvement is very likely implicated in this newly described therapeutic property.
Collapse
Affiliation(s)
- M Guazzi
- Cardiopulmonary Unit, Cardiology Division, University of Milan, San Paolo Hospital, 20142 Milan, Italy.
| | | | | | | | | |
Collapse
|
18
|
Ojeda L, Cruz D, Reina G, Borenstein J. Current-Based Slippage Detection and Odometry Correction for Mobile Robots and Planetary Rovers. IEEE T ROBOT 2006. [DOI: 10.1109/tro.2005.862480] [Citation(s) in RCA: 98] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
19
|
Miranda C, Camacho E, Reina G, Turiño J, Rodríguez-Granger J, Yeste R, Bautista MF, García M, Alados JC, De la Rosa M. Isolation of Mycoplasma hominis from extragenital cultures. Eur J Clin Microbiol Infect Dis 2005; 24:334-7. [PMID: 15868155 DOI: 10.1007/s10096-005-1326-6] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
In order to document the characteristics of extragenital Mycoplasma hominis infections, the clinical features of 36 cases in which M. hominis was isolated from extragenital sites of adult patients were reviewed. In most cases, the organism was detected in conventional bacterial cultures (from specimens obtained from surgical and immunosuppressed patients) that had been incubated for at least 72 h. The results indicate that in cases in which M. hominis involvement is suspected, prolonged incubation or specialized microbiological techniques for detecting Mycoplasma spp. should be employed.
Collapse
Affiliation(s)
- C Miranda
- Department of Microbiology, Virgen de las Nieves University Hospital, Avenida Fuerzas Armadas 2, 18014 Granada, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
|
21
|
|
22
|
Ricciardiello L, Cannizzaro O, D'Angelo A, Ederle A, Gerace G, Iaquinto G, Reina G, Scarpulla G, Spadaccini A, Olivieri A, Tosatto R, Fossi S, Pozzato P, Zagari M, Bazzoli F, Roda E. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. Aliment Pharmacol Ther 1998; 12:533-7. [PMID: 9678812 DOI: 10.1046/j.1365-2036.1998.00342.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
BACKGROUND This multicentre, randomized study was designed to assess the clinical efficacy, safety and tolerability of three novel 7-day triple therapies containing ranitidine bismuth citrate (RBC) and two antibiotics. METHODS We studied patients with non-ulcer dyspepsia and gastritis who were randomly assigned to one of three treatment regimens given for 7 days in a b.d. dosing schedule: RBC 400 mg plus clarithromycin 250 mg and tinidazole 500 mg (RBCCT): RBC 400 mg plus clarithromycin 500 mg and amoxycillin 1 g (RBCCA); RBC 400 mg plus tinidazole 500 mg and amoxycillin 1 g (RBCTA). H. pylori status was determined by CLO-test, histology and 13C-urea breath test. A repeat breath test was performed at least 28 days after completion of therapy to assess eradication. RESULTS One hundred and fifty-seven patients were eligible for intention-to-treat analysis (ITT) and 140 patients completed the study and returned for assessment of eradication. Intention-to-treat cure rates were 78% with RBCCT, 71% with RBCCA and 61% with RBCTA. An all-patients-treated analysis (APT), performed on evaluable patients, demonstrated eradication rates of 85% with RBCCT, 81% with RBCCA and 70% with RBCTA. No statistically significant difference was found between treatment groups. Twenty-four patients experienced side-effects, but in only seven cases was treatment discontinued due to adverse events. CONCLUSIONS A 7-day course of RBC, clarithromycin and either tinidazole or amoxycillin provides a good rate of H. pylori eradication. Three novel RBC-based triple therapies proved to be safe and well tolerated, with discontinuations due to side-effects occurring in less than 5% of cases.
Collapse
Affiliation(s)
- L Ricciardiello
- Gastroenterology Unit, Policlinico S. Orsola, Bologna, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina G, Morabito A, Balestrieri G, Tincani A, Gershwin ME, Meroni PL. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies. Clin Exp Immunol 1998; 112:144-51. [PMID: 9566803 PMCID: PMC1904940 DOI: 10.1046/j.1365-2249.1998.00562.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
The aim of this study was to characterize the antigen specificity and to evaluate the diagnostic and prognostic value of anti-mitochondrial M5 type antibodies (AMA M5). Fifty-eight patients selected on the basis of their AMA M5 positivity were investigated in relationship to their clinical and serological profile. Cross-absorption studies, Western blotting and immunoprecipitation analysis were carried out for AMA M5 antigen specificity characterization. Most patients had a diagnosis of systemic lupus erythematosus (SLE) (65.5%) or of primary anti-phospholipid syndrome (PAPS) (24%); all the patients were positive for IgG or IgM anti-cardiolipin (anti-CL) antibodies and 49% of them also displayed lupus anticoagulant (LA) activity. Anti-beta2-glycoprotein I (beta2-GPI) IgG were detectable in 30/38 sera (78.9%) and IgM in 34/38 (89.4%). While anti-CL and anti-beta2-GPI IgG antibodies were significantly associated with history of thrombosis and fetal loss, AMA M5 displayed a statistical association only for thrombocytopenia and recurrent fetal loss. Absorption with human beta2-GPI both in free solution or in solid phase as well as with CL liposomes or CL/beta2-GPI liposome complexes did not affect AMA M5 fluorescence. While AMA M5 activity is absorbed by whole mitochondrial preparations, no specific reactivities against several human, bovine and rat mitochondrial proteins could be detected in Western blotting and immunoprecipitation studies. AMA M5 appear to be detectable in both primary and secondary APS, displaying a strong association with the presence of thrombocytopenia and fetal loss. Although strictly related to anti-phospholipid antibodies, AMA M5, anti-CL and anti-beta2-GPI antibodies represent distinct serological markers of the APS.
Collapse
Affiliation(s)
- L La Rosa
- Istituto di Medicina Interna, Malattie Infettive & Immunopatologia, IRCCS Policlinico, University of Milan, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Serum magnesium levels may not accurately reflect overall magnesium homeostasis. To clarify the relationship between serum and intracellular magnesium concentrations in chronic alcoholism, we determined intralymphocytic magnesium levels and serum magnesium, sodium and potassium concentrations in ten chronic alcoholic subjects admitted to the emergency room during acute ethanol intoxication, and compared the results to those of 14 healthy nonalcoholic controls. Serum magnesium, sodium and potassium concentrations were within the normal range in both groups of subjects and determination of intralymphocytic magnesium levels revealed a nonsignificant decrease in alcoholic subjects compared to controls. In conclusion, serum and intralymphocytic magnesium concentrations did not differ between chronic alcoholics and controls in our population; the results of the present study do not support the practice of routine magnesium administration to chronic alcoholics in the emergency room setting.
Collapse
Affiliation(s)
- T Princi
- Department of Physiology and Pathology, University of Trieste, Italy
| | | | | | | | | | | |
Collapse
|
25
|
Tanzillo A, Caruso F, Arcerito M, Pinieri ML, Pedullà S, Reina G, Pedullà G. [Warthin's tumor]. MINERVA CHIR 1997; 52:851-6. [PMID: 9324674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Cystoadenolymphoma is a rare tumor of salivary glands. The classic clinical picture is described and four cases are presented. Current concepts of etiology, histopathology, treatment and prognosis are discussed. Authors remark the significance of radical treatment and the care must be taken not to damage the facial nerve.
Collapse
Affiliation(s)
- A Tanzillo
- Divisione Chirurgia d'Urgenza e P.S. Ospedale Vittorio Emanuele II, Catania
| | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
Modern emergency medicine requires the use of temporary observation (TO) to direct diagnostic and therapeutic decisions. The position of TO in the hospital structure has been well defined in the legal sense, inasmuch as it provides the preparatory stage for the final specialized medical treatment the patient will receive after admission. TO has become indispensable in emergency medicine to provide prompt treatment of critically ill patients and to clarify as rapidly as possible uncertain cases to avoid unnecessary admissions and transfers. To operate effectively, the service of TO must be provided well-trained staff, suitable physical facilities and support services, and access to rapid specialty consultations within the emergency room environment.
Collapse
Affiliation(s)
- G Reina
- Autonomous First Aid, Reception and Temporary Observation Service of the Azienda per i Servizi Sanitari n.1 Triestina, Italy
| |
Collapse
|
27
|
Reina G, Rubinacci A, Moro GL, Moro L, Pecile A. Time-relationship between bone growth and increment of bone mineral content in growing rats. MINERVA ENDOCRINOL 1995; 20:211-6. [PMID: 8709917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The aim of the study was to describe the time-relationship between the growth rate of the rat tibia and the increase rate of its mineral content. Appositional and endochondral bone growth rates were derived from sequential X-rays measurements of tibial widening and lengthening, respectively; the increase rate of bone mineral content was derived from sequential photon absorptiometry measurements of the proximal tibio-fibular site. The time-relationship of appositional growth rate and endochondral growth rate versus bone mineral content increase rate was mathematically described. The results allow a better understanding of the time-course of two distinct features of bone growth: increase in size and increase in mineral content.
Collapse
Affiliation(s)
- G Reina
- Department of Pharmacology, University of Milano
| | | | | | | | | |
Collapse
|
28
|
Princi T, Artero M, Battigelli D, Malusà N, Reina G. Effect of acute ethanol administration on serum magnesium concentration in the rabbit. Boll Soc Ital Biol Sper 1994; 70:51-6. [PMID: 7840953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- T Princi
- Institute of Physiology, University of Trieste
| | | | | | | | | |
Collapse
|
29
|
Vitale G, Reina G, Mansueto S, Malta R, Gambino G, Mocciaro C, D'Agostino R, Dieli M, Cillari E. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients. Clin Exp Immunol 1992; 90:219-22. [PMID: 1424277 PMCID: PMC1554630 DOI: 10.1111/j.1365-2249.1992.tb07932.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Sera from nine Sicilian patients with confirmed visceral leishmaniasis (Leishmania donovani infantum; VL), at the moment of the diagnosis, during the course of the disease and after clinical recovery, were analysed for the concentration of soluble IL-2 receptor (sIL-2R). The results show that sIL-2R is a marker of disease activity, since it is in high concentration at the beginning of infection and returns to the normal range following successful chemotherapy. At the same time of serum analysis for sIL-2R, peripheral blood mononuclear cells (PBMC) of VL patients were stimulated with phytohaemagglutinin (PHA) or antigen and supernatant tested for IL-2 and interferon-gamma (IFN-gamma) production. Data demonstrate that there is an inverse relation between concentration of IL-2 and IFN-gamma in the supernatants and sIL-2R secretion in the sera.
Collapse
Affiliation(s)
- G Vitale
- Institute of Medical Pathology, University of Palermo, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Reina G, Moro L, Rubinacci A, Bettica P, Villani P, Rovis L, Moro GL, de Bernard B, Pecile A. A new mathematical model to study bone turnover in growing rats. Biochem Biophys Res Commun 1992; 185:47-53. [PMID: 1599486 DOI: 10.1016/s0006-291x(05)80953-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
A new mathematical model for the study of bone turnover in growing rats was developed. The model predicts a linear relationship between bone mineral content (BMC) and biochemical markers (BMK) of bone turnover assuming that rats are growing, bone turnover is profoundly affected by skeletal maturation, and resorption and formation are physiologically balanced. The model validation was performed by measuring galactosyl-hydroxylysine (GHYL) and hydroxyproline (HYP) in urines. This mathematical evidence supports our proposed use of the specific bone resorption marker GHYL to predict bone mineral content. Further studies on bone turnover will be possible by the application of the same approach.
Collapse
Affiliation(s)
- G Reina
- Department of Pharmacology, Chemotherapy and Medical Toxicology, University of Milano, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Nisoli E, Tonello C, Memo M, Pizzi M, Spano P, Reina G, Carruba MO. Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats. Eur J Pharmacol 1992; 216:81-6. [PMID: 1356088 DOI: 10.1016/0014-2999(92)90212-m] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
We studied the adaptive changes of the locomotor effects of lisuride, a selective agonist for dopamine (DA) D2 receptors, and the functional state of D1 and D2 receptors after repeated administration of lisuride at a dose supposed to act preferentially on DA autoreceptors. Rats were treated daily with saline or lisuride, at a dose that causes a significant reduction in locomotor activity when given to naive rats (25 micrograms/kg i.p.), for 33 days and the effect of different challenging doses of the drug on locomotor activity was measured at different times during and after the treatment. The functional state of D1 and D2 DA receptors was evaluated by measuring SKF 82526-stimulated and LY 171555-inhibited adenylate cyclase (AC) activity in the caudatus/putamen, nucleus accumbens and substantia nigra and naive and chronically treated rats. There was a progressive decline in the ability of lisuride to decrease locomotor activity in rats given daily injections of lisuride, and there was a marked reduction in the threshold dose of lisuride for causing hypermotility. The functional state of DA receptors, positively or negatively linked to AC activity, was not modified by the treatment. The most suitable explanation of the reported adaptive behavioral changes is a down-regulation of DA autoreceptors after chronic treatment with presynaptic doses of lisuride.
Collapse
MESH Headings
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs & derivatives
- 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology
- Adenylyl Cyclases/metabolism
- Analysis of Variance
- Animals
- Brain/drug effects
- Brain/metabolism
- Down-Regulation
- Drug Tolerance
- Ergolines/pharmacology
- Fenoldopam
- Lisuride/administration & dosage
- Lisuride/pharmacology
- Male
- Motor Activity/drug effects
- Quinpirole
- Radioimmunoassay
- Rats
- Rats, Inbred Strains
- Receptors, Dopamine/drug effects
- Receptors, Dopamine/metabolism
Collapse
Affiliation(s)
- E Nisoli
- Department of Biomedical Sciences and Biotechnologies, School of Medicine, University of Brescia, Italy
| | | | | | | | | | | | | |
Collapse
|
32
|
Festini G, Gregorutti S, Reina G, Bellis GB. Isolated intraperitoneal bladder rupture in patients with alcohol intoxication and minor abdominal trauma. Ann Emerg Med 1991; 20:1371-2. [PMID: 1746742 DOI: 10.1016/s0196-0644(05)81082-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Rupture of the urinary bladder secondary to abdominal trauma is uncommon and is usually associated with visceral or bone injuries; less than 10% of all cases occur without associated injuries. We present two cases of bladder rupture in intoxicated patients after minor abdominal trauma and without evidence of associated injuries. Given the absence of any symptoms in either case, we did not initially suspect bladder rupture. One of the two patients also presented with an intravesical herniation of the rectosigmoidal junction.
Collapse
Affiliation(s)
- G Festini
- Emergency Department, Cattinara Hospital, Trieste, Italy
| | | | | | | |
Collapse
|
33
|
Mansueto S, Vitale G, Mocciaro C, Librizzi R, Friscia I, Usticano V, Gambino G, Reina G. Laboratory diagnosis of boutonneuse fever by enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 1989; 83:855-7. [PMID: 2694514 DOI: 10.1016/0035-9203(89)90353-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Little is known about the use of the enzyme-linked immunosorbent assay (ELISA) in the diagnosis of boutonneuse fever, and the reports which do exist have concerned the use of a strain of African origin and a peroxidase-labelled conjugate. We have used, as antigen, a Sicilian strain of Rickettsia conorii recently isolated from a patient with boutonneuse fever and anti-human immunoglobulins G and M labelled with alkaline phosphatase as conjugate. 432 (84.6%) of 500 sera from patients with boutonneuse fever, 4.4% of 384 sera from patients with various other pathologies, and 2.9% of 204 sera from blood donors gave positive reactions. The ELISA was highly sensitive and specific in the diagnosis of boutonneuse fever, and seems to be the test of choice for sero-epidemiological investigations, and when a large number of specimens must be examined. The test is more sensitive than the indirect immunofluorescence test, at least in the early stage of the disease (44.9% vs 21.3% positive respectively), and a long time after an acute attack.
Collapse
Affiliation(s)
- S Mansueto
- Cattedra di Patologia Speciale Medica e Metodologia Clinica, University of Palermo, Italy
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Cella SG, Moiraghi V, Minuto F, Barreca A, Cocchi D, De Gennaro Colona V, Reina G, Müller EE. Prolonged fasting or clonidine can restore the defective growth hormone secretion in old dogs. Acta Endocrinol (Copenh) 1989; 121:177-84. [PMID: 2505465 DOI: 10.1530/acta.0.1210177] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Age-related changes in GH secretion were studied in dog. In preliminary experiments, administration of GH-releasing hormone (GHRH-40, 2 micrograms/kg, iv) or the alpha 2-adrenoceptor agonist clonidine (4 micrograms/kg, iv) elicited significantly higher plasma GH rises in 3 to 4 years old than in 10 to 14 years old beagle dogs. The pulsatile patterns of GH secretion in both young and old dogs under baseline conditions and after prolonged fasting or clonidine administration were studied. Samples were taken every 10 min from 09.00 to 15.00 h from five young and five old dogs of both sexes. Under baseline conditions, GH peak frequency, total peak area, and integrated GH secretion were significantly lower in old than in young dogs. In old dogs, 5-day complete fasting or 14-day clonidine administration (75 micrograms/dog, po, twice daily) increased the frequency and amplitude of spontaneous GH bursts, the total peak area, and the integrated GH secretion. After either stimulus, the GH secretory pattern was quantitatively and qualitatively indistinguishable from that of young dogs under baseline conditions. Similarly, the foregoing indices were significantly increased in young dogs by either stimulus, except for the inability of clonidine to affect peak frequency. These data demonstrate that the defective GH secretion in old dogs is not irreversible, since it is normalized when old dogs are exposed to central nervous system-directed stimuli.
Collapse
Affiliation(s)
- S G Cella
- Department of Pharmacology, Chemotherapy and Toxicology, University of Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Lonati F, Reina G, Candotti F, Pea G, Fasciolo F, Castellani A. [A predictive model of vascular instability in dialysis]. MINERVA UROL NEFROL 1989; 41:77-8. [PMID: 2762976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
36
|
Amendola A, Labath N, Nivolianitou Z, Reina G. Application of Dylam to the Safety Analysis of Chemical Processes. International Journal of Quality & Reliability Management 1988. [DOI: 10.1108/eb002901] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Safety analysis of hazardous processes requires the use of models to simulate dangerous transient conditions and to assess the availability of the relevant mitigating and protective systems. As this article shows, these two needs can be fairly well satisfied by the application of DYLAM, which is able to take into account the dynamic aspects of the interaction between time‐dependent operational variables, control and protection systems and human interventions at both nominal and failure conditions and, therefore, presents significant advantages with respect to the normally utilised fault trees/event trees.
Collapse
|
37
|
Reina G, Gullo A, Romano E. [Coma in myxedema. Clinical contribution]. Minerva Anestesiol 1982; 48:65-8. [PMID: 7078754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Coma due to myxoedema was first reported in 1879, and recent surveys have shown that only 150 cases are mentioned in the literature. Two cases successfully treated in a resuscitation department over the last six years are presented. The problems presented by patients of this type are discussed, and stress is laid on the importance of resuscitatory and intensive management, at least until resolution of the coma.
Collapse
|
38
|
Pedretti D, Casadei GL, Reina G, Conti-Tronconi B. Antiacetylcholinesterase antibodies: enzyme antibodies interaction. Pharmacol Res Commun 1981; 13:541-57. [PMID: 6794042 DOI: 10.1016/s0031-6989(81)80024-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
39
|
Zingone B, Nigro R, Caramuta U, Reina G. [Right aortic arch and "congenital" left suvclavian steal syndrome. Observations on an operated case]. Minerva Cardioangiol 1979; 27:527-32. [PMID: 548800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
40
|
Nigro R, Reina G, Caramuta U. [Acute thrombosis of the axillary vein (minor pectoralis muscle syndrome). Considerations on 3 surgically treated cases]. Minerva Cardioangiol 1979; 27:227-32. [PMID: 471246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
41
|
Aguggini G, Meucci M, Reina G. The excretion of L-dopa metabolites at different hours of the day. Curr Ther Res Clin Exp 1972; 14:749-57. [PMID: 4629113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|